02291 心泰醫療
SCIENTECH
SCIENTECH
| Listing Date | 2022/11/08 |
| Listing Price | 29.150 |
Quote
Subscription Result
- Subscription Rate2.11x
- Guarantee One Lot Size1 lot
- One Lot Success Rate100%
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
LEPU Scientech Medical Technology (Shanghai) founded in 1994, it have been dedicated to the research, development, manufacture and commercialization of interventional medical devices primarily targeting structural heart diseases. It is a leading interventional medical device provider in China for congenital heart diseases (“CHD”), with a market share of 38% in terms of revenue recognized for the sales in China in 2021. It is the largest manufacturer of CHD occluder products and the related procedural accessories in China.
The Group had a comprehensive product portfolio of 20 marketed occluder products and nine occluder product candidates as well as 21 major heart valve product candidates. All of products are developed in-house. It includes primarily various CHD occluder products and PFO occluder products and LAA occluder products for prevention of cardioembolic stroke and related symptoms, including migraine, peripheral arterial embolism, and decompression sickness.
The Group has established research and development centers in Beijing and Shanghai.
It also had an expansive collection of intellectual property rights including 232 registered patents and 51 pending patent applications in China as well as 14 patents under application in the United States and the European Union.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 1000 |
GLOBAL OFFERING
| No. of Offer Shares | 22.46M H shares |
| No. of International Offer Shares | 20.21M H shares |
| No. of HK Offer Shares | 2.25M H shares |
| Offer Price | $29.15 - $31.45 |
| Stock Code | 2291 |
| Sponsor(s) | China International Capital Corporation Hong Kong Securities Limited |
| Underwriter(s) | China International Capital Corporation Hong Kong Securities Limited, CLSA Limited, China Galaxy International Securities (Hong Kong) Co., Limited, Huatai Financial Holdings (Hong Kong) Limited, Valuable Capital Limited |
TIME TABLE
| Application Period | Oct 27 (Thu) - noon, Nov 01 (Tue) |
| Price Determination Date | Nov 01 (Tue) |
| Result Announcement Date | On or before Nov 07 (Mon) |
| Result Announcement Date | On or before Nov 07 (Mon) |
| Dealings in Shares commence on | Nov 08, 2022. (Tue) |
Reallocation of Shares Offered
| Times of HK Offer Shares Subscription | 15X - 50X | 50X - 100X | Over 100X |
| % of total shares reallocated to HK Offer | 30% | 40% | 50% |
Sales Statistics (HKD)
| Offer Price | $29.15 - $31.45 |
| Capitalization (H Shares) | 10.11B - 10.91B |
| NAV / share ($) | $4.71 - $4.86 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 30.30, the net proceeds raised would be HKD 592.10M, of which |
| 50.7% : Fund research and development activities |
| 24.3% : Sales and marketing activities |
| 5% : Expand production capacity and strengthen manufacturing capabilities |
| 10% : Fund potential strategic investments and acquisitions |
| 10% : Working capital |
IPO NEWS
| 08/11/2022 16:08 |
| {New Stock}SCIENTECH(02291) ends flat at HK$29.15 |
| 08/11/2022 09:20 |
| {New Stock}SCIENTECH(02291) opens up 2.23% at HK$29.8 |
| 07/11/2022 18:35 |
| {New Stock}SCIENTECH(02291) ends up 0.34% on grey market |
| 07/11/2022 16:20 |
| {New Stock}SCIENTECH(02291) up 2.92% at HK$30 on grey market |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).